Live
Endpoints NewsBMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campusPromega BlogTiny Edits, Big Harvests: How a Massive Mutation Screen Could Transform Crop EngineeringPharmaVoiceChina’s biotech rise sparks new US industry allianceFierceBiotechStruggling Liminatus pays $320M in stock for CAR-T biotech InnocsAIEli LillyLilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling - BioSpaceCellScavenger receptor class F member 2 is an intracellular receptor for hepatitis B virusCellHarnessing citizen science to contextualize adaptation mechanism discoveryEndpoints NewsLilly’s triple agonist still leads among late-stage obesity assetsEli LillyExperimental Drug Yields Dramatic Weight Loss - The New York TimesEli LillyEli Lilly maintains M&A streak with $202m Engage Bio buyout - Pharmaceutical TechnologyFierceBiotechInfex, following in Insmed’s footsteps, advances lung disease candidate after clearing phase 2aThermo FisherThermo Fisher Scientific’s SWOT analysis: stock navigates growth amid strategic shifts - Investing.com

Archive

Total 11702
Page 548 / 651
Query --